Alembic Aims To Build On Booming US Business
Launches Let US Sales Leap By 61%
With its predominantly solid-dose portfolio in the US producing strong growth, India’s Alembic Pharmaceuticals is increasingly securing FDA clearance to push into differentiated dosage forms.
